glutamic acid has been researched along with bumetanide in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (7.14) | 18.2507 |
| 2000's | 8 (57.14) | 29.6817 |
| 2010's | 3 (21.43) | 24.3611 |
| 2020's | 2 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Murali, SG; Sun, D | 1 |
| Akaike, N; Jang, IS; Jeong, HJ | 1 |
| Flagella, M; Kintner, DB; Shull, GE; Su, G; Sun, D | 1 |
| Beck, J; Kintner, DB; Lenart, B; Sun, D | 1 |
| Bauser-Heaton, HD; Bohlen, HG; Song, J | 1 |
| Jiang, Z; Li, B; Shen, W | 1 |
| Brodwick, M; Ishibashi, H; Kitamura, A; Nabekura, J; Takatsuru, Y; Watanabe, M | 1 |
| Kafitz, KW; Kelly, T; Roderigo, C; Rose, CR | 1 |
| Begum, R; Jovanovic, JN; Long, P; Mercer, A; Sihra, TS; Stephens, GJ | 1 |
| Akaike, N; Nonaka, K; Shin, MC; Wakita, M; Yamamoto, S; Yoshimura, M | 1 |
| MacKenzie, G; Maguire, J; Moss, SJ; O'Toole, KK | 1 |
| Dai, Y; Deng, S; Du, X; Feng, J; Huang, CC; Ji, Y; Li, F; Lin, CP; Luo, Q; Sahakian, BJ; Shen, C; Tang, Y; Wang, K; Xu, M; Yu, J; Zhang, L | 1 |
| Dai, Y; Deng, S; Du, X; Feng, J; He, H; Ji, Y; Langley, C; Li, F; Li, WG; Liu, X; Luo, Q; Sahakian, BJ; Tang, Y; Wang, K; Yu, J; Zhang, J; Zhang, L; Zhou, X | 1 |
2 trial(s) available for glutamic acid and bumetanide
| Article | Year |
|---|---|
Symptom improvement in children with autism spectrum disorder following bumetanide administration is associated with decreased GABA/glutamate ratios.
Topics: Autism Spectrum Disorder; Autistic Disorder; Bumetanide; Child; Child, Preschool; gamma-Aminobutyric Acid; Glutamic Acid; Humans | 2020 |
Improved symptoms following bumetanide treatment in children aged 3-6 years with autism spectrum disorder: a randomized, double-blind, placebo-controlled trial.
Topics: Autism Spectrum Disorder; Autistic Disorder; Bumetanide; Child; Child, Preschool; gamma-Aminobutyric Acid; Glutamic Acid; Humans | 2021 |
12 other study(ies) available for glutamic acid and bumetanide
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Stimulation of Na+-K+-2Cl- cotransporter in neuronal cells by excitatory neurotransmitter glutamate.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Bumetanide; Carrier Proteins; Cycloleucine; Dizocilpine Maleate; Excitatory Amino Acid Agents; Gene Expression Regulation; Glutamic Acid; Humans; Kinetics; N-Methylaspartate; Neuroblastoma; Neurons; Potassium; Receptors, Glutamate; Sodium-Potassium-Chloride Symporters; Tumor Cells, Cultured | 1998 |
Contribution of the Na-K-Cl cotransporter on GABA(A) receptor-mediated presynaptic depolarization in excitatory nerve terminals.
Topics: Animals; Bumetanide; Carrier Proteins; Chlorides; Dose-Response Relationship, Drug; Excitatory Postsynaptic Potentials; GABA Agonists; gamma-Aminobutyric Acid; Glutamic Acid; Hypothalamus; In Vitro Techniques; Muscimol; Neurons; Presynaptic Terminals; Rats; Rats, Wistar; Receptors, GABA-A; Sodium-Potassium-Chloride Symporters; Synaptic Transmission; Tetrodotoxin; Ventromedial Hypothalamic Nucleus | 2001 |
Astrocytes from Na(+)-K(+)-Cl(-) cotransporter-null mice exhibit absence of swelling and decrease in EAA release.
Topics: 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; Animals; Aspartic Acid; Astrocytes; Bumetanide; Cell Size; Cells, Cultured; Cerebral Cortex; Chlorides; Diuretics; Glutamic Acid; Mice; Mice, Knockout; Microscopy, Fluorescence; Potassium; Rats; Sodium; Sodium-Potassium-Chloride Symporters | 2002 |
Na-K-Cl cotransporter contributes to glutamate-mediated excitotoxicity.
Topics: Animals; Astrocytes; Bumetanide; Cell Death; Cell Hypoxia; Cell Survival; Cells, Cultured; Chlorides; Diuretics; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Glucose; Glutamic Acid; Neurons; Neurotoxins; Oxygen; Rats; Sodium; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Potassium-Chloride Symporters | 2003 |
Cerebral microvascular nNOS responds to lowered oxygen tension through a bumetanide-sensitive cotransporter and sodium-calcium exchanger.
Topics: Amiloride; Animals; Arterioles; Bumetanide; Caveolin 1; Cerebral Arteries; Cerebral Cortex; Cerebrovascular Circulation; Diuretics; Enzyme Activation; Glutamic Acid; Male; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Oxygen; Peptide Fragments; Rats; Rats, Sprague-Dawley; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Calcium Exchanger; Sodium-Hydrogen Exchangers; Sodium-Potassium-Chloride Symporters; Thiourea; Vasoconstriction; Vasodilation | 2008 |
Glycine input induces the synaptic facilitation in salamander rod photoreceptors.
Topics: Animals; Bumetanide; Calcium Channels; Glutamic Acid; Glycine; Glycine Agents; Immunohistochemistry; Retina; Retinal Bipolar Cells; Retinal Horizontal Cells; Retinal Rod Photoreceptor Cells; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Potassium-Chloride Symporters; Solute Carrier Family 12, Member 2; Strychnine; Synapses; Time Factors; Urodela | 2008 |
Sustained depolarizing shift of the GABA reversal potential by glutamate receptor activation in hippocampal neurons.
Topics: Analysis of Variance; Animals; Bumetanide; Calcium; Chlorides; Electric Stimulation; Embryo, Mammalian; Enzyme Inhibitors; Excitatory Amino Acid Agents; Furosemide; GABA Agonists; gamma-Aminobutyric Acid; Glutamic Acid; Hippocampus; Membrane Potentials; Muscimol; Neural Inhibition; Neural Pathways; Neurons; Organ Culture Techniques; Patch-Clamp Techniques; Rats; Receptors, Glutamate; Sodium Potassium Chloride Symporter Inhibitors; Time Factors | 2008 |
Ammonium-evoked alterations in intracellular sodium and pH reduce glial glutamate transport activity.
Topics: Aging; Animals; Aspartic Acid; Astrocytes; Biological Transport; Bumetanide; Cells, Cultured; Central Nervous System Agents; D-Aspartic Acid; Glutamic Acid; Hippocampus; Hydrogen-Ion Concentration; Immunohistochemistry; Quaternary Ammonium Compounds; Rats; Rats, Wistar; Sodium; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Potassium-Chloride Symporters; Solute Carrier Family 12, Member 2 | 2009 |
Nerve Terminal GABAA Receptors Activate Ca2+/Calmodulin-dependent Signaling to Inhibit Voltage-gated Ca2+ Influx and Glutamate Release.
Topics: Animals; Barium; Bumetanide; Calcium; Calcium Channels; Calcium Signaling; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Calmodulin; Glutamic Acid; Male; Mice; Mice, Knockout; Rats; Rats, Sprague-Dawley; Receptors, GABA-A; Sodium Potassium Chloride Symporter Inhibitors; Synapsins; Synaptosomes | 2009 |
GABA(A) receptor-mediated presynaptic inhibition on glutamatergic transmission.
Topics: Animals; Bicuculline; Bumetanide; Excitatory Postsynaptic Potentials; GABA-A Receptor Agonists; GABA-A Receptor Antagonists; Glutamic Acid; Hippocampus; Muscimol; Neurons; Patch-Clamp Techniques; Presynaptic Terminals; Rats; Rats, Wistar; Receptors, GABA-A; Receptors, Glutamate; Sodium Potassium Chloride Symporter Inhibitors; Synaptic Transmission | 2011 |
Compromised GABAergic inhibition contributes to tumor-associated epilepsy.
Topics: Animals; Brain; Brain Neoplasms; Bumetanide; Cell Line, Tumor; Disease Models, Animal; Epilepsy; gamma-Aminobutyric Acid; Glioma; Glutamic Acid; K Cl- Cotransporters; Male; Mice, Inbred C57BL; Mice, Nude; Mice, Transgenic; Phosphorylation; Rats; Sodium Potassium Chloride Symporter Inhibitors; Solute Carrier Family 12, Member 2; Symporters; Tissue Culture Techniques | 2016 |